Third Rock Ventures III, L.P.

Insider Reports History

Entity
Company
Location
29 Newbury Street, 3 Rd Floor, Boston, MA
Signature
/s/ Kevin Gillis, Chief Operating Officer of TRV GP III, LLC, general partner of Third Rock Ventures GP III, L.P., general partner of Third Rock Ventures III, L.P.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Third Rock Ventures III, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Revolution Medicines, Inc. 10%+ Owner Common Stock 5.1M $138M $27.00 Jun 8, 2022 Direct
PLIANT THERAPEUTICS, INC. 10%+ Owner Common Stock 2.13M $36.7M $17.23 Nov 29, 2022 Indirect
Nurix Therapeutics, Inc. 10%+ Owner Common Stock 3.42M $34.2M $10.00 May 6, 2021 Direct
PLIANT THERAPEUTICS, INC. 10%+ Owner Common Stock 1.84M $31.7M $17.23 Nov 29, 2022 Direct
Voyager Therapeutics, Inc. 10%+ Owner Common Stock 3.19M $22.8M $7.15 Feb 2, 2023 Direct
Fulcrum Therapeutics, Inc. 10%+ Owner Common Stock 2.34M $7.76M $3.31 Dec 13, 2022 Indirect
Fulcrum Therapeutics, Inc. 10%+ Owner Common Stock 1.96M $6.49M $3.31 Dec 13, 2022 Direct
Jounce Therapeutics, Inc. 10%+ Owner Common Stock 1.15M $2.13M $1.85 Nov 12, 2021 Direct
Nurix Therapeutics, Inc. 10%+ Owner Common Stock 86.8K $868K $10.00 May 6, 2021 Indirect
Jounce Therapeutics, Inc. 10%+ Owner Common Stock 284K $525K $1.85 Nov 12, 2021 Indirect
Revolution Medicines, Inc. 10%+ Owner Common Stock 0 $27.00 Jun 8, 2022 Indirect

Insider Reports Filed by Third Rock Ventures III, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VYGR Voyager Therapeutics, Inc. Feb 2, 2023 1 $0 4 Feb 6, 2023 10%+ Owner
VYGR Voyager Therapeutics, Inc. Jan 30, 2023 3 -$3.59M 4 Feb 1, 2023 10%+ Owner
VYGR Voyager Therapeutics, Inc. Jan 27, 2023 1 -$451K 4 Jan 31, 2023 10%+ Owner
VYGR Voyager Therapeutics, Inc. Jan 24, 2023 2 -$1.39M 4 Jan 26, 2023 10%+ Owner
VYGR Voyager Therapeutics, Inc. Jan 20, 2023 2 -$1.41M 4 Jan 24, 2023 10%+ Owner
FULC Fulcrum Therapeutics, Inc. Dec 13, 2022 1 $0 4 Dec 15, 2022 10%+ Owner
PLRX PLIANT THERAPEUTICS, INC. Nov 29, 2022 1 $0 4 Dec 1, 2022 10%+ Owner
PLRX PLIANT THERAPEUTICS, INC. Sep 20, 2022 1 $0 4 Sep 22, 2022 10%+ Owner
VYGR Voyager Therapeutics, Inc. Aug 24, 2022 2 -$2.16M 4 Aug 26, 2022 10%+ Owner
VYGR Voyager Therapeutics, Inc. Aug 16, 2022 1 -$776K 4 Aug 18, 2022 10%+ Owner
VYGR Voyager Therapeutics, Inc. Aug 12, 2022 2 -$2.95M 4 Aug 16, 2022 10%+ Owner
RVMD Revolution Medicines, Inc. Jun 8, 2022 1 -$8.5M 4 Jun 10, 2022 10%+ Owner
JNCE Jounce Therapeutics, Inc. Nov 12, 2021 1 -$15.9M 4 Nov 16, 2021 10%+ Owner
FULC Fulcrum Therapeutics, Inc. Nov 10, 2021 1 $0 4 Nov 12, 2021 10%+ Owner
FULC Fulcrum Therapeutics, Inc. Sep 22, 2021 1 $0 4 Sep 24, 2021 10%+ Owner
NRIX Nurix Therapeutics, Inc. May 6, 2021 1 $0 4 May 10, 2021 10%+ Owner